TCM
NVS icon

Tributary Capital Management’s Novartis NVS Stock Holding History

Tributary Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-279
Closed -$19K – 214
2013
Q3 		$19K Sell
279
-84,844
-100% -$5.61M ﹤0.01% 196
2013
Q2 		$5.39M Buy
+85,123
New +$5.54M 0.88% 10

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tributary Capital Management's NVS Position: Q4 2013 in Review

Tributary Capital Management sold out of Novartis (NVS) in Q4 2013, closing a stake of 279 shares — an estimated $19K sold.

Tributary Capital Management first reported a position in NVS in Q2 2013 and held it in 2 quarters. The position peaked at $5.39M in Q2 2013. 815 funds tracked by Wall St. Rank hold NVS as of Q4 2013.

  • Tributary Capital Management reported no remaining Novartis position as of Q4 2013 after selling out during the quarter.
  • Tributary Capital Management sold 279 Novartis shares in Q4 2013, an estimated $19K.
  • Tributary Capital Management first reported a position in Novartis in Q2 2013 and held it in 2 quarters.
  • Tributary Capital Management's Novartis position peaked at $5.39M in Q2 2013.
  • 815 funds tracked by Wall St. Rank held Novartis as of Q4 2013.

Based on Tributary Capital Management's 13F filing for Q4 2013, filed 6 Feb 2014.